Consumed in capsule form daily, Probio8 delivers eight different strains of beneficial probiotics, prebiotics and postbiotics, and each daily dose contains up to 23 billion healthy bacteria. In addition, Probio8's more potent formulation represents a notable upgrade to
"The pursuit of exceptional health is central to everything we do here," said John "JT" Thatch, CEO of SHRG. "We know that gut health is foundational to overall wellness, so developing a product as powerful as Probio8 means our customers have the greatest possible advantage when it comes to achieving their personal health goals."
"We've never been content to rest on the success of our existing products alone," continued Thatch. "We're committed to always expanding and improving what we do. Probio8 is a great example of how, even with our best products, we're always looking for opportunities to innovate and to serve our customers better."
Probio8 is gluten-free, sugar-free and vegan. A 30-day supply is available for purchase now, along with
For more information, visit www.thehappyco.com.
About
Additional information is contained in the Company’s 10-Q and 10-K filings with the
Visit: www.SHRGInc.com
Forward-Looking Statements
The statements contained in this press release, those which are not purely historical or which depend upon future events, may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Statements regarding the Company's expectations, hopes, beliefs, intentions or strategies regarding the future, including the Company's operating margin and rolling average annual growth in tangible book value per share, constitute forward-looking statements. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements because of various factors. All forward-looking statements included in this press release are based on information available to the Company on the date hereof, and the Company assumes no obligation to update any such forward-looking statement. Prospective investors should also consult the risks factors described from time to time in the Company's Reports on Forms 10-K, 10-Q and 8-K and Annual Reports to Shareholders.
Company Contact:
Investor Relations
(469) 304-9400 Ext. 201
Info@SHRGinc.com
Corporate Communications:
InvestorBrandNetwork (IBN)
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com
Source:
2023 GlobeNewswire, Inc., source